Showing results (81-90 of 196) with videos related to
Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|March 6, 2009
In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancerDonato Cosco, Alessandra Bulotta, Monica Ventura, et al.Cancer Chemotherapy and Pharmacology|October 9, 2007
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of ageRaffaele Addeo, Vincenzo Faiola, Rosario Guarrasi, et al.Cancer Cell International|January 8, 2026
PARP1 trapping activates cGAS-STING pathway to induce immunogenic cell death in multiple myelomaGiada Juli, Domenica Ronchetti, Stefania Signorelli, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patientsCirino Botta, Elena Bestoso, Serena Apollinari, et al.International Journal of Oncology|April 6, 2005
Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agentsPierfrancesco Tassone, Simona Blotta, Camillo Palmieri, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 26, 2026
CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancerMichela Destito, Caterina Battaglia, Paolo Zaffino, et al.Oncotarget|October 21, 2016
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigationNicoletta Staropoli, Domenico Ciliberto, Silvia Chiellino, et al.Scientific Reports|December 22, 2017
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatmentMayra Rachele Zarone, Gabriella Misso, Anna Grimaldi, et al.Oncotarget|June 10, 2015
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myelomaMaria Teresa Di Martino, Pietro Hiram Guzzi, Daniele Caracciolo, et al.Journal of Experimental & Clinical Cancer Research : CR|May 3, 2018
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signalingMaria Francesca Santolla, Rosamaria Lappano, Francesca Cirillo, et al.Pageof 20